Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,900 Ocular
clinical trials

Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Group of Washington
405
mi
from 02139
Fairfax, VA
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
Status: Enrolling, Phase III
Updated: 12/31/1969
Associated Retinal Consultants PC
740
mi
from 02139
Grand Rapids, MI
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Consultants of Houston
1606
mi
from 02139
Houston, TX
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Wisconsin
929
mi
from 02139
Madison, WI
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
Status: Enrolling, Phase III
Updated: 12/31/1969
Associated Retina Consultants
2292
mi
from 02139
Phoenix, AZ
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Consultants, San Diego
2561
mi
from 02139
Poway, CA
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
Status: Enrolling, Phase III
Updated: 12/31/1969
Black Hills Regional Eye Institute
1610
mi
from 02139
Rapid City, SD
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
Status: Enrolling, Phase III
Updated: 12/31/1969
Retinal Consultants of San Antonio
1763
mi
from 02139
San Antonio, TX
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Tufts Medical Center
2
mi
from 02139
Boston, MA
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Southeast Retina Center, P.C.
851
mi
from 02139
Augusta, GA
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
The Retina Care Center
356
mi
from 02139
Baltimore, MD
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Mid Atlantic Retina
407
mi
from 02139
Bethlehem, PA
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina-Vitreous Associates Medical Group
2595
mi
from 02139
Beverly Hills, CA
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Group of Washington
390
mi
from 02139
Chevy Chase, MD
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Duke University, Duke Eye Center
607
mi
from 02139
Durham, NC
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Ophthalmic Consultants of Long Island
177
mi
from 02139
Lynbrook, NY
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Tennessee Retina, P.C.
940
mi
from 02139
Nashville, TN
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
New York Eye and Ear Infirmary of Mount Sinai
227
mi
from 02139
New York, NY
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Vitreous-Retina-Macula Consultants of NY,PC
227
mi
from 02139
New York, NY
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Sierra Eye Associates
2511
mi
from 02139
Reno, NV
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
California Retina Consultants
2649
mi
from 02139
Santa Barbara, CA
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
American Institute of Research
2579
mi
from 02139
Whittier, CA
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Tufts Medical Center
2
mi
from 02139
Boston, MA
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Univ of Minnesota
1116
mi
from 02139
Minneapolis, MN
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Southeast Retina Center, P.C.
851
mi
from 02139
Augusta, GA
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina-Vitreous Associates Medical Group
2595
mi
from 02139
Beverly Hills, CA
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Group of Washington
390
mi
from 02139
Chevy Chase, MD
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Cincinnati Eye Institute
735
mi
from 02139
Cincinnati, OH
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Health Center
1250
mi
from 02139
Fort Myers, FL
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Illinois Retina Associates
874
mi
from 02139
Joliet, IL
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Associates of Kentucky
763
mi
from 02139
Lexington, KY
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Valley Retina Institute, P.A.
1895
mi
from 02139
McAllen, TX
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Tennessee Retina, P.C.
940
mi
from 02139
Nashville, TN
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Sierra Eye Associates
2511
mi
from 02139
Reno, NV
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Ophthalmic Consultants of Long Island
176
mi
from 02139
Rockville Centre, NY
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
California Retina Consultants
2649
mi
from 02139
Santa Barbara, CA
Click here to add this to my saved trials
Primary Open-angle Glaucoma Clinical Trial
DE-117 Spectrum 5 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Arizona Eye Center
2285
mi
from 02139
Chandler, AZ
Click here to add this to my saved trials
Primary Open-angle Glaucoma Clinical Trial
DE-117 Spectrum 5 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Mundorf Eye Center
719
mi
from 02139
Charlotte, NC
Click here to add this to my saved trials
Primary Open-angle Glaucoma Clinical Trial
DE-117 Spectrum 5 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Abrams Eye Center
546
mi
from 02139
Cleveland, OH
Click here to add this to my saved trials
Primary Open-angle Glaucoma Clinical Trial
DE-117 Spectrum 5 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Global Research Management
2586
mi
from 02139
Glendale, CA
Click here to add this to my saved trials
Primary Open-angle Glaucoma Clinical Trial
DE-117 Spectrum 5 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Shettle Eye Research
1194
mi
from 02139
Largo, FL
Click here to add this to my saved trials
Primary Open-angle Glaucoma Clinical Trial
DE-117 Spectrum 5 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Eye Research Foundation
2586
mi
from 02139
Newport Beach, CA
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Apioc Contact Lens Feasibility
Status: Enrolling
Updated: 12/31/1969
Ohio State University
640
mi
from 02139
Columbus, OH
Click here to add this to my saved trials
Glaucoma and Ocular Hypertension Clinical Trial
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Eye Associates of Fort Myers
1246
mi
from 02139
Fort Myers, FL
Click here to add this to my saved trials
Glaucoma and Ocular Hypertension Clinical Trial
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
North Valley Eye Medical Group, Inc.
2592
mi
from 02139
Mission Hills, CA
Click here to add this to my saved trials
Glaucoma and Ocular Hypertension Clinical Trial
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Arizona Glaucoma Specialists
2283
mi
from 02139
Phoenix, AZ
Click here to add this to my saved trials
Glaucoma and Ocular Hypertension Clinical Trial
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Arizona Eye Center
2285
mi
from 02139
Chandler, AZ
Click here to add this to my saved trials
Glaucoma and Ocular Hypertension Clinical Trial
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Ophthalmic Institute
1079
mi
from 02139
Gainesville, FL
Click here to add this to my saved trials
Glaucoma and Ocular Hypertension Clinical Trial
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Silverstein Eye Centers
1241
mi
from 02139
Kansas City, MO
Click here to add this to my saved trials
Glaucoma and Ocular Hypertension Clinical Trial
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Eye Research Foundation
2586
mi
from 02139
Newport Beach, CA
Click here to add this to my saved trials
Glaucoma and Ocular Hypertension Clinical Trial
A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study
Status: Enrolling, Phase III
Updated: 12/31/1969
University of California at San Francisco
2692
mi
from 02139
San Francisco, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Ophthalmology Clinical Trial
Evaluation of Safety and Efficacy of Brimonidine Tartrate Ophthalmic Suspension
Status: Enrolling, Phase III
Updated: 12/31/1969
SPARC Site 11
1256
mi
from 02139
Miami, FL
Click here to add this to my saved trials
Ophthalmology Clinical Trial
A Post-Market Evaluation of LipiFlow Treatment in Cataract Surgery Practice
Status: Enrolling
Updated: 12/31/1969
Empire Eye & Laser Center
2590
mi
from 02139
Bakersfield, CA
Click here to add this to my saved trials
Non Infectious Uveitis Clinical Trial
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina-Vitreous Associates Medical Group
2595
mi
from 02139
Beverly Hills, CA
Click here to add this to my saved trials
Non Infectious Uveitis Clinical Trial
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Associates of Kentucky
763
mi
from 02139
Lexington, KY
Click here to add this to my saved trials
Non Infectious Uveitis Clinical Trial
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
Status: Enrolling, Phase III
Updated: 12/31/1969
Vanderbilt Eye Institute
939
mi
from 02139
Nashville, TN
Click here to add this to my saved trials
Non Infectious Uveitis Clinical Trial
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
Status: Enrolling, Phase III
Updated: 12/31/1969
Metropolitan Eye Research and Surgery Institute
182
mi
from 02139
Palisades Park, NJ
Click here to add this to my saved trials
Non Infectious Uveitis Clinical Trial
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
Status: Enrolling, Phase III
Updated: 12/31/1969
Arizona Retina and Vitreous Consultants
2292
mi
from 02139
Phoenix, AZ
Click here to add this to my saved trials
Non Infectious Uveitis Clinical Trial
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
Status: Enrolling, Phase III
Updated: 12/31/1969
West Coast Retina
2689
mi
from 02139
San Francisco, CA
Click here to add this to my saved trials
Non Infectious Uveitis Clinical Trial
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Centers, P.C.
2277
mi
from 02139
Tucson, AZ
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Retina Associates
1564
mi
from 02139
Arlington, TX
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Research Center
1690
mi
from 02139
Austin, TX
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Status: Enrolling, Phase III
Updated: 12/31/1969
Cleveland Clinic Foundation
544
mi
from 02139
Cleveland, OH
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Status: Enrolling, Phase III
Updated: 12/31/1969
The Retina Partners
2597
mi
from 02139
Encino, CA
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Northwest, PC
2530
mi
from 02139
Portland, OR
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retinal Consultants Medical Group, Inc.
2622
mi
from 02139
Sacramento, CA
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Associates of Utah
2091
mi
from 02139
Salt Lake City, UT
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Status: Enrolling, Phase III
Updated: 12/31/1969
Orange County Retina Medical Group
2579
mi
from 02139
Santa Ana, CA
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy
Status: Enrolling, Phase IV
Updated: 12/31/1969
Stein Eye Institute (UCLA)
2598
mi
from 02139
Los Angeles, CA
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
1703
mi
from 02139
Abilene, TX
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
548
mi
from 02139
Cleveland, OH
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
732
mi
from 02139
Fairfield, OH
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
1250
mi
from 02139
Fort Myers, FL
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
1574
mi
from 02139
Fort Worth, TX
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
2586
mi
from 02139
Huntington Beach, CA
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
2668
mi
from 02139
Mountain View, CA
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
1356
mi
from 02139
New Orleans, LA
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
2682
mi
from 02139
Oakland, CA
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis
1764
mi
from 02139
San Antonio, TX
Click here to add this to my saved trials
Cataract Clinical Trial
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
Status: Enrolling
Updated: 12/31/1969
Advanced Vision Care
2588
mi
from 02139
Los Angeles, CA
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye Drops
Status: Enrolling
Updated: 12/31/1969
The Ohio State University College of Optometry
640
mi
from 02139
Columbus, OH
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Evaluation of Systane Complete for the Treatment of Contact Lens Discomfort
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Alabama at Birmingham
1052
mi
from 02139
Birmingham, AL
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Evaluation of Systane Complete for the Treatment of Contact Lens Discomfort
Status: Enrolling, Phase IV
Updated: 12/31/1969
Southern College of Optometry
1130
mi
from 02139
Memphis, TN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling, Phase
Updated: 12/31/1969
Rutgers-RWJMS
216
mi
from 02139
New Brunswick, NJ
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Post-Approval Study of the TECNIS SYMFONY® Toric Lenses
Status: Enrolling
Updated: 12/31/1969
Oakland Ophthalmic Surgery
616
mi
from 02139
Birmingham, MI
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Post-Approval Study of the TECNIS SYMFONY® Toric Lenses
Status: Enrolling
Updated: 12/31/1969
Florida Eye Microsurgical Institute
1205
mi
from 02139
Boynton Beach, FL
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Post-Approval Study of the TECNIS SYMFONY® Toric Lenses
Status: Enrolling
Updated: 12/31/1969
The Eye Associates of Manatee
1214
mi
from 02139
Bradenton, FL
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Post-Approval Study of the TECNIS SYMFONY® Toric Lenses
Status: Enrolling
Updated: 12/31/1969
Scripps Clinic Medical Group, Inc
2575
mi
from 02139
La Jolla, CA
Click here to add this to my saved trials
Amblyopia Clinical Trial
Augmenting Patching Treatment for Amblyopia With Physical Exercise
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
1079
mi
from 02139
Rochester, MN
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retinal Diagnostic Center
2680
mi
from 02139
Campbell, CA
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
Status: Enrolling, Phase III
Updated: 12/31/1969
The Retina Partners
2597
mi
from 02139
Encino, CA
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Associated Retinal Consultants PC
740
mi
from 02139
Grand Rapids, MI
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina and Vitreous of Texas
1601
mi
from 02139
Houston, TX
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Specialty Institute
1214
mi
from 02139
Pensacola, FL
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Consultants, San Diego
2561
mi
from 02139
Poway, CA
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Rocky Mountain Retina
2092
mi
from 02139
Salt Lake City, UT
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Consultants
142
mi
from 02139
SLingerlands, NY
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Southeast Retina Center, P.C.
851
mi
from 02139
Augusta, GA
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)
Status: Enrolling, Phase III
Updated: 12/31/1969
The Retina Care Center
356
mi
from 02139
Baltimore, MD
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)
Status: Enrolling, Phase III
Updated: 12/31/1969
Retina Consultants of Nevada
2367
mi
from 02139
Las Vegas, NV
Click here to add this to my saved trials
1 … 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 … 29